Results 271 to 280 of about 4,586,589 (282)
Some of the next articles are maybe not open access.
Progress and Controversies: Radiation Therapy for Invasive Breast Cancer
Ca-A Cancer Journal for Clinicians, 2014Reshma Jagsi
exaly
ANTI-AMYLOID ANTIBODIES AND THEIR USE IN DIAGNOSIS AND THERAPY OF AMYLOID DISEASES
2008HORN UWE +3 more
openaire +3 more sources
[Precautions for Neurosurgeons in Administering Anti-Amyloid β Antibody Therapy].
No shinkei geka. Neurological surgeryIn Japan, anti-amyloid β (Aβ) monoclonal antibodies, including lecanemab and donanemab, have recently been approved as disease-modifying therapies for early-stage Alzheimer's disease (AD). These drugs, developed based on the amyloid cascade hypothesis, target toxic Aβ aggregates: lecanemab selectively binds to soluble protofibrils, while donanemab ...
openaire +1 more source
The Evolving Landscape of Tissue-Agnostic Therapies in Precision Oncology
Ca-A Cancer Journal for CliniciansHoward A Burris +2 more
exaly
Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
2006KLUNK WILLIAM E, MATHIS JR CHESTER A
openaire +4 more sources
182 Estimating eligibility for anti-amyloid therapy: a Nottingham perspective
182 Estimating eligibility for anti-amyloid therapy: a Nottingham perspectiveShao Beili +2 more
openaire +1 more source
Is Rural America Ready for Anti-amyloid Therapy? (P1-3.019)
NeurologyJamil Numan, Micaela Owens
openaire +1 more source
Managing Mild Cognitive Impairment in the Age of Anti-amyloid Therapies
The American Journal of Geriatric PsychiatryAmy Abramowitz +4 more
openaire +1 more source
EPH87 Estimating the Eligible Population for Anti-Amyloid Therapy in Finland
Value in HealthIva Tadic +2 more
openaire +1 more source